Pharmaceutical composition comprising PARP inhibitors
US12318385B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 15, 2019 |
| Grant date | Jun 3, 2025 |
| Priority date | — |
| Expiry date | Jan 18, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/4866
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A solid dispersion for PARP inhibitors, comprising a compound represented by formula I and a carrier material, wherein the carrier material comprises polyvinylpyrrolidone. A pharmaceutical composition, comprising a solid dispersion, a filler, a disintegrating agent and a lubricant. A preparation method for the solid dispersion. Use of the solid dispersion or the pharmaceutical composition in the preparation of drugs for treating cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.